PETAH TIKVA, Israel, March 13, 2025 /PRNewswire/ — Strauss Group Ltd. (TASE: STRS), announces today that it will release its fourth quarter and full year 2024 financial results March 25, 2025. The release will be followed by a webinar earnings call at 15:30 local Israeli time/ 13:30 UK time/ 9:30 a.m. ET to discuss the results.
The webinar will be hosted by the company’s management to review the results and will be followed by a question and answers session. To participate in the webinar please use the following link:
https://us02web.zoom.us/webinar/register/WN_REnvfeGuT4WtXuWht_7alA
Webinar ID: 893 5546 6751
Questions for the questions and answers session may be submitted in advance to: Rivka.neufeld@strauss-group.com
The management’s review will be accompanied by a presentation which will be available on the Investor Relations section of our website on Tuesday, March 25th, 2025:
https://ir.strauss-group.com/company-presentations/quarterly-presentations /
Strauss Group’s Q4 2024 earnings press release and financial statements will be available on the Company’s website:
https://ir.strauss-group.com/financial /
https://ir.strauss-group.com/earning-releases/
A recording of the webinar will be available on the company’s website shortly following the webinar.
For further information, please contact:
Rivka Neufeld
Investor Relations Manager
+972-54-4224146
rivka.neufeld@strauss-group.com
www.strauss-group.com
SOURCE Strauss Group Ltd.
2026 Outlook: automated Agentic AI workflows will rapidly emerge as business imperatives to meet patient…
2026 Outlook: automated Agentic AI workflows will rapidly emerge as business imperatives to meet patient…
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#CMSAlignedNetwork--Netsmart, an industry-leading provider of healthcare technology solutions and services for community-based…
From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are…
Potential Schedule III Status Could Improve Legal Clarity for Patients Traveling from Colombia to the…
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…